Summary : Liver cancer, also known as hepatic cancer and primary hepatic cancer, is a relatively rare form of cancer that has…
admin
-
-
AgrochemicalsGlobal MarketPharma Science & Research
mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022
by adminby adminSynopsis : mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus…
-
CompaniesPfizerRegulatoryU.S FDA
FDA Pushes Pfizer COVID Vaccine for 6 Month to 5 Years Kids
by adminby adminSummary : A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old…
-
AgrochemicalsGlobal Market
Fast Radius Announces Completion of Merger with ECP Environmental Growth Opportunities Corp.
by adminby adminSummary : Fast Radius will trade on Nasdaq under ticker symbol “FSRD” “Fast Radius”), a cloud manufacturing company, today announced the successful…
-
AgrochemicalsGlobal Market
ION receives continued listing standard notice from the NYSE
by adminby adminSynopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock…
-
RegulatorySanofiU.S FDA
FDA approves Enjaymo™ (sutimlimab-jome), First Treatment for use in Patients with Cold Agglutinin Disease
by adminby adminSummary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…
-
Agrochemicals
Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
by adminby adminSynopsis : Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative…
-
Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for…
-
CompaniesGlobal MarketNovartis
Financials Indicate Novartis’ Sandoz Division Could Be a Tough Sell
by adminby adminSynopsis : Novartis reported its full-year financials this week for 2021, and overall, the news was good. Full-year net sales grew 4%,…
-
AgrochemicalsBiogenGlobal Market
Biogen’s Aduhelm Grabs the Spotlight at User Fee Renewals Hearing
by adminby adminSummary – The House Energy and Commerce Committee’s health panel met to discuss renewing user fee agreements used to fund the U.S.…
